Recombinant Lactococcus lactis expressing bioactive exendin-4 to promote insulin secretion and beta-cell proliferation in vitro

2017 ◽  
Vol 101 (19) ◽  
pp. 7177-7186 ◽  
Author(s):  
Zhu Zeng ◽  
Rui Yu ◽  
Fanglei Zuo ◽  
Bo Zhang ◽  
Huiqin Ma ◽  
...  
2010 ◽  
pp. P3-482-P3-482
Author(s):  
HE Levitt ◽  
TJ Cyphert ◽  
JL Pascoe ◽  
DA Hollern ◽  
N Abraham ◽  
...  

2015 ◽  
Vol 35 (6) ◽  
pp. 2223-2232 ◽  
Author(s):  
Chaoxun Wang ◽  
Xiaopan Chen ◽  
Xiaoying Ding ◽  
Yanju He ◽  
Chengying Gu ◽  
...  

Background/Aims: Prevention of diabetes requires maintenance of a functional beta-cell mass, the postnatal growth of which depends on beta cell proliferation. Past studies have shown evidence of an effect of an incretin analogue, Exendin-4, in promoting beta cell proliferation, whereas the underlying molecular mechanisms are not completely understood. Methods: Here we studied the effects of Exendin-4 on beta cell proliferation in vitro and in vivo through analysing BrdU-incorporated beta cells. We also analysed the effects of Exendin-4 on beta cell mass in vivo, and on beta cell number in vitro. Then, we applied specific inhibitors of different signalling pathways and analysed their effects on Exendin-4-induced beta cell proliferation. Results: Exendin-4 increased beta cell proliferation in vitro and in vivo, resulting in significant increases in beta cell mass and beta cell number, respectively. Inhibition of PI3K/Akt signalling, but not inhibition of either ERK/MAPK pathway, or JNK pathway, significantly abolished the effects of Exendin-4 in promoting beta cell proliferation. Conclusion: Exendin-4 promotes beta cell proliferation via PI3k/Akt signaling pathway.


2019 ◽  
Vol 234 (11) ◽  
pp. 19852-19865 ◽  
Author(s):  
Daniela A. Maschio ◽  
Valquíria A. Matheus ◽  
Carla B. Collares‐Buzato

2019 ◽  
Vol 240 (2) ◽  
pp. 123-132 ◽  
Author(s):  
Niels L Mulder ◽  
Rick Havinga ◽  
Joost Kluiver ◽  
Albert K Groen ◽  
Janine K Kruit

MicroRNAs have emerged as essential regulators of beta cell function and beta cell proliferation. One of these microRNAs, miR-132, is highly induced in several obesity models and increased expression of miR-132 in vitro modulates glucose-stimulated insulin secretion. The aim of this study was to investigate the therapeutic benefits of miR-132 overexpression on beta cell function in vivo. To overexpress miR-132 specifically in beta cells, we employed adeno-associated virus (AAV8)-mediated gene transfer using the rat insulin promoter in a double-stranded, self-complementary AAV vector to overexpress miR-132. Treatment of mice with dsAAV8-RIP-mir132 increased miR-132 expression in beta cells without impacting expression of miR-212 or miR-375. Surprisingly, overexpression of miR-132 did not impact glucose homeostasis in chow-fed animals. Overexpression of miR-132 did improve insulin secretion and hence glucose homeostasis in high-fat diet-fed mice. Furthermore, miR-132 overexpression increased beta cell proliferation in mice fed a high-fat diet. In conclusion, our data show that AAV8-mediated gene transfer of miR-132 to beta cells improves beta cell function in mice in response to a high-fat diet. This suggests that increased miR-132 expression is beneficial for beta cell function during hyperglycemia and obesity.


Development ◽  
1983 ◽  
Vol 75 (1) ◽  
pp. 303-312
Author(s):  
Hue-Lee Cheng Kaung

The effect of glucose on growth of the beta cell population was characterized in rat pancreatic organ culture. The effect was monitored by measuring [3H]thymidine labelling indices of beta cells during the culture period and by quantitation of beta cell population size at the end of the culture period. Foetal and neonatal pancreases and different glucose levels were compared. Glucose was found to be effective in stimulating the beta cell proliferation and beta cell population increase at 300 mg/100 ml in 18-day foetal pancreatic explants, but not in 3-day neonatal explants, when compared to the control level of 1OOmg/1OOml. A higher level of glucose (500 mg/100 ml) was ineffective and may even inhibit beta cell population growth. The higher than control levels of glucose (300 mg/100 ml and 500 mg/100 ml) were able to stimulate insulin secretion in neonatal tissue, but not in foetal tissue, although foetal tissue may develop such response later in culture. These results suggest that glucose stimulates beta cell proliferation and insulin secretion through different mechanisms. They further show that the potentiality for beta cell proliferation under glucose stimulation decreases with age of the explants and that the capacity for beta cell to proliferate as a function of glucose stimulation is limited.


Sign in / Sign up

Export Citation Format

Share Document